Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Forns

Showing results (231-240 of 298) with videos related to

Pageof 30
Sort By:
Annals of Hepatology|June 14, 2014
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis CJavier Ampuero, José A Del Campo, Lourdes Rojas, et al.
Scientific Reports|May 21, 2026
Early hepatitis B and delta virus kinetics in patients undergoing liver transplantationSara Battistella, Anna Pocurull, Thais Leonel, et al.
Journal of Viral Hepatitis|August 25, 2018
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antiviralsElena Perpiñán, Noelia Caro-Pérez, Neris García-González, et al.
Antiviral Therapy|March 27, 2009
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentAndreas Erhardt, Katja Deterding, Yves Benhamou, et al.
The American Journal of Gastroenterology|August 12, 2010
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting responseConrado M Fernández-Rodríguez, Sonia Alonso, Stella M Martinez, et al.
The New England Journal of Medicine|April 15, 2014
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosisFred Poordad, Christophe Hezode, Roger Trinh, et al.
Science Translational Medicine|June 27, 2014
HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humansFelix Bohne, María-Carlota Londoño, Carlos Benítez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2025
Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson DiseaseCamilla Lorenzen, Karen Dons, Clàudia García-Solà, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2021
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological responseMattias Mandorfer, Fanny Turon, Sabela Lens, et al.
Journal of Hepatology|December 5, 2020
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Pageof 30

Showing results (231-240 of 298) with videos related to

Sort By:
Pageof 30
Annals of Hepatology|June 14, 2014
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis CJavier Ampuero, José A Del Campo, Lourdes Rojas, et al.
Scientific Reports|May 21, 2026
Early hepatitis B and delta virus kinetics in patients undergoing liver transplantationSara Battistella, Anna Pocurull, Thais Leonel, et al.
Journal of Viral Hepatitis|August 25, 2018
Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antiviralsElena Perpiñán, Noelia Caro-Pérez, Neris García-González, et al.
Antiviral Therapy|March 27, 2009
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatmentAndreas Erhardt, Katja Deterding, Yves Benhamou, et al.
The American Journal of Gastroenterology|August 12, 2010
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting responseConrado M Fernández-Rodríguez, Sonia Alonso, Stella M Martinez, et al.
The New England Journal of Medicine|April 15, 2014
ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosisFred Poordad, Christophe Hezode, Roger Trinh, et al.
Science Translational Medicine|June 27, 2014
HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humansFelix Bohne, María-Carlota Londoño, Carlos Benítez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2025
Relative Exchangeable Copper, Exchangeable Copper and Total Copper in the Diagnosis of Wilson DiseaseCamilla Lorenzen, Karen Dons, Clàudia García-Solà, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 9, 2021
Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological responseMattias Mandorfer, Fanny Turon, Sabela Lens, et al.
Journal of Hepatology|December 5, 2020
Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patientsMireia García-López, Sabela Lens, Laura J Pallett, et al.
Pageof 30